Delivery Order SPE2DB24D3015-SPE2DB24FFXQW
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TROKENDI XR 200 MG capsules. The order has a potential value of $2,506.29 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and the contract does not have a set-aside designation. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,064.50 firm fixed-price delivery order is for the supply of 4566177898 TROKENDI XR 100 MG CAPSULE 30S, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TROKENDI XR 200 MG CAPSULE 30S. The contract has a firm fixed price of $2,311.17 and a period of performance through July 9, 2025. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,251.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567985141 - TROKENDI XR 200 MG CAPSULE 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TROKENDI XR 100 MG CAPSULE 30S, a neurological medication, with a ceiling value of $4,648.71 and a period of performance through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,076.16 contract is for the delivery of Trokendi XR 25 mg capsules to support military treatment programs and medical facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TROKENDI XR 200 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $5,854.12 and an ultimate completion date of August 16, 2024. The contract is not set aside for any specific business type. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of 4567909893 - TROKENDI XR 50 MG CAPSULE 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $27,447.94 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of medical...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FB4D6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,172.70 and is a Firm Fixed Price Delivery Order contract for the supply of TROKENDI XR 100 MG CAPSULE 30S. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 28, 2025. This contract is not designated as a...